Glecaprevir/pibrentasvir in patients aged 3–17 years with chronic hepatitis C: Real‐life data from the POLAC project
Our study confirms that 8 weeks of therapy with GLE/PIB in children with chronic hepatitis C is highly effective and safe.
Authors
- Magdalena Marczyńska (ORCID: https://orcid.org/0000-0001-5731-6346)
- Anna Dobrzeniecka (ORCID: https://orcid.org/0000-0003-1731-2329)
- Maria Pokorska‐Śpiewak (ORCID: https://orcid.org/0000-0001-7783-6904)
- Małgorzata Aniszewska (ORCID: https://orcid.org/0000-0002-6964-0706)
- Ewa Talarek (ORCID: https://orcid.org/0000-0002-3466-0782)
- Marta Troszczyńska
Institutions
- Medical University of Warsaw (PL)
- Central Clinical Hospital (PL)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1002/jpn3.70241
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00